SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-002555
Filing Date
2022-03-01
Accepted
2022-03-01 16:13:21
Documents
106
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cara-20211231x10k.htm   iXBRL 10-K 3552592
2 EX-10.13 cara-20211231xex10d13.htm EX-10.13 35113
3 EX-10.14 cara-20211231xex10d14.htm EX-10.14 121156
4 EX-23.1 cara-20211231xex23d1.htm EX-23.1 12683
5 EX-31.1 cara-20211231xex31d1.htm EX-31.1 11580
6 EX-31.2 cara-20211231xex31d2.htm EX-31.2 11746
7 EX-32.1 cara-20211231xex32d1.htm EX-32.1 10308
8 GRAPHIC cara-20211231x10k004.jpg GRAPHIC 32167
  Complete submission text file 0001558370-22-002555.txt   14612910

Data Files

Seq Description Document Type Size
9 EX-101.SCH cara-20211231.xsd EX-101.SCH 87300
10 EX-101.CAL cara-20211231_cal.xml EX-101.CAL 77932
11 EX-101.DEF cara-20211231_def.xml EX-101.DEF 437931
12 EX-101.LAB cara-20211231_lab.xml EX-101.LAB 747256
13 EX-101.PRE cara-20211231_pre.xml EX-101.PRE 673285
100 EXTRACTED XBRL INSTANCE DOCUMENT cara-20211231x10k_htm.xml XML 2646896
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36279 | Film No.: 22698141
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences